IDEAYA Biosciences Announces 2024 Asco Oral Presentation Summary Results of the Investigator-Sponsored Phase 2 Study of Darovasertib for Neo-Adjuvant Uveal Melanoma
IDEAYA Biosciences公布了研究者赞助的Darovasertib治疗新辅助葡萄膜黑色素瘤的2期研究的2024年Asco 口头陈述摘要结果
IDEAYA Biosciences Announces 2024 Asco Oral Presentation Summary Results of the Investigator-Sponsored Phase 2 Study of Darovasertib for Neo-Adjuvant Uveal Melanoma
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.